MedPlus Subsidiary Receives Drug License Suspension Order
⚖️ $MEDPLUS disclosed that its subsidiary Optival Health Solutions Private Limited has received a 10-day drug license suspension order from the FDA Maharashtra. The order cites alleged violations under the Drugs and Cosmetics Act, 1940, and pertains to the subsidiary's pharmacy operations.
#StockInNews#FundamentalViews
818 likes·73 comments

















